Molecular characterization of breast cancer cell response to metabolic drugs
Lucía Trilla‐Fuertes, Angelo Gámez‐Pozo, Jorge M. Arevalillo, Mariana Díaz‐Almirón, Guillermo Prado-Vázquez, Andrea Zapater‐Moros, Hilario Navarro, Rosa Aras‐López, Irene Dapía, Rocío López‐Vacas, Paolo Nanni, Sara Llorente-Armijo, Pedro Arias, Alberto Manuel Borobia, Paloma Maı́n, , Juan Ángel Fresno Vara
The paper characterizes breast cancer cell responses to metabolic drugs using proteomics and computational models, showing heterogeneous effects and pathway-level flux changes.
Oncotarget · Jan 8, 2018Peer-reviewedSystems Biology